nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0633	0.264	CiPCiCtD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0612	0.255	CiPCiCtD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0592	0.247	CiPCiCtD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0559	0.233	CiPCiCtD
Dexamethasone—brain cancer—Triamcinolone—hematologic cancer	0.0483	0.337	CpDpCtD
Dexamethasone—Betamethasone—hematologic cancer	0.0444	0.263	CrCtD
Dexamethasone—Triamcinolone—hematologic cancer	0.0434	0.256	CrCtD
Dexamethasone—Prednisone—hematologic cancer	0.0412	0.243	CrCtD
Dexamethasone—Prednisolone—hematologic cancer	0.0402	0.238	CrCtD
Dexamethasone—ABCG2—hematologic cancer	0.0263	0.439	CbGaD
Dexamethasone—colon cancer—Betamethasone—hematologic cancer	0.0263	0.183	CpDpCtD
Dexamethasone—brain cancer—Betamethasone—hematologic cancer	0.0263	0.183	CpDpCtD
Dexamethasone—NR3C1—hematologic cancer	0.0227	0.379	CbGaD
Dexamethasone—NR0B1—Vorinostat—hematologic cancer	0.0197	0.121	CbGbCtD
Dexamethasone—kidney cancer—Betamethasone—hematologic cancer	0.019	0.133	CpDpCtD
Dexamethasone—prostate cancer—Betamethasone—hematologic cancer	0.0137	0.0959	CpDpCtD
Dexamethasone—ABCB1—hematologic cancer	0.011	0.183	CbGaD
Dexamethasone—breast cancer—Betamethasone—hematologic cancer	0.00965	0.0673	CpDpCtD
Dexamethasone—PLA2G1B—Betamethasone—hematologic cancer	0.00827	0.0508	CbGbCtD
Dexamethasone—NR0B1—Vincristine—hematologic cancer	0.00638	0.0392	CbGbCtD
Dexamethasone—CYP1B1—Procarbazine—hematologic cancer	0.00568	0.0349	CbGbCtD
Dexamethasone—NR3C2—Betamethasone—hematologic cancer	0.00368	0.0226	CbGbCtD
Dexamethasone—NR3C2—Prednisolone—hematologic cancer	0.00363	0.0223	CbGbCtD
Dexamethasone—NOS2—Doxorubicin—hematologic cancer	0.00334	0.0205	CbGbCtD
Dexamethasone—CYP1B1—Daunorubicin—hematologic cancer	0.00304	0.0187	CbGbCtD
Dexamethasone—ABCB11—Daunorubicin—hematologic cancer	0.00304	0.0187	CbGbCtD
Dexamethasone—CYP4A11—Cisplatin—hematologic cancer	0.00286	0.0176	CbGbCtD
Dexamethasone—SLCO1A2—Chlorambucil—hematologic cancer	0.00273	0.0168	CbGbCtD
Dexamethasone—PTGS2—Lenalidomide—hematologic cancer	0.0027	0.0166	CbGbCtD
Dexamethasone—ABCG2—Clofarabine—hematologic cancer	0.00247	0.0152	CbGbCtD
Dexamethasone—PGR—Betamethasone—hematologic cancer	0.00238	0.0146	CbGbCtD
Dexamethasone—CYP1B1—Dasatinib—hematologic cancer	0.00187	0.0115	CbGbCtD
Dexamethasone—CYP1B1—Mitoxantrone—hematologic cancer	0.00185	0.0114	CbGbCtD
Dexamethasone—CYP17A1—ovarian follicle—hematologic cancer	0.00179	0.113	CbGeAlD
Dexamethasone—CYP2A6—Methoxsalen—hematologic cancer	0.00172	0.0106	CbGbCtD
Dexamethasone—CYP11A1—ovarian follicle—hematologic cancer	0.00167	0.105	CbGeAlD
Dexamethasone—ABCC2—Daunorubicin—hematologic cancer	0.0016	0.00984	CbGbCtD
Dexamethasone—Fluticasone furoate—Betamethasone—hematologic cancer	0.00151	0.0119	CrCrCtD
Dexamethasone—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00148	0.0116	CrCrCtD
Dexamethasone—CYP1A1—Methoxsalen—hematologic cancer	0.00147	0.00903	CbGbCtD
Dexamethasone—ABCG2—Daunorubicin—hematologic cancer	0.00145	0.0089	CbGbCtD
Dexamethasone—PTGS2—Thalidomide—hematologic cancer	0.00144	0.00886	CbGbCtD
Dexamethasone—CYP2B6—Thiotepa—hematologic cancer	0.00144	0.00885	CbGbCtD
Dexamethasone—NR3C1—Triamcinolone—hematologic cancer	0.00141	0.0087	CbGbCtD
Dexamethasone—Flurandrenolide—Betamethasone—hematologic cancer	0.00141	0.0111	CrCrCtD
Dexamethasone—CYP1A1—Bortezomib—hematologic cancer	0.0014	0.00859	CbGbCtD
Dexamethasone—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00136	0.0107	CrCrCtD
Dexamethasone—CYP19A1—Betamethasone—hematologic cancer	0.00134	0.00822	CbGbCtD
Dexamethasone—CYP1A1—Daunorubicin—hematologic cancer	0.00134	0.00822	CbGbCtD
Dexamethasone—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00133	0.0105	CrCrCtD
Dexamethasone—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00132	0.0104	CrCrCtD
Dexamethasone—Difluprednate—Betamethasone—hematologic cancer	0.00132	0.0104	CrCrCtD
Dexamethasone—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00132	0.0104	CrCrCtD
Dexamethasone—ABCB11—Vinblastine—hematologic cancer	0.0013	0.00796	CbGbCtD
Dexamethasone—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00129	0.0101	CrCrCtD
Dexamethasone—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00129	0.0101	CrCrCtD
Dexamethasone—Difluprednate—Triamcinolone—hematologic cancer	0.00129	0.0101	CrCrCtD
Dexamethasone—Flurandrenolide—Prednisolone—hematologic cancer	0.00127	0.01	CrCrCtD
Dexamethasone—ABCB11—Vincristine—hematologic cancer	0.00127	0.00783	CbGbCtD
Dexamethasone—ABCG2—Teniposide—hematologic cancer	0.00126	0.00773	CbGbCtD
Dexamethasone—CYP2A6—Ifosfamide—hematologic cancer	0.00125	0.00771	CbGbCtD
Dexamethasone—Testolactone—Betamethasone—hematologic cancer	0.00124	0.00974	CrCrCtD
Dexamethasone—Beclomethasone—Betamethasone—hematologic cancer	0.00124	0.00974	CrCrCtD
Dexamethasone—Clocortolone—Betamethasone—hematologic cancer	0.00124	0.00974	CrCrCtD
Dexamethasone—Prednicarbate—Betamethasone—hematologic cancer	0.00124	0.00974	CrCrCtD
Dexamethasone—Fluocinonide—Betamethasone—hematologic cancer	0.00124	0.00974	CrCrCtD
Dexamethasone—CYP1A1—Thalidomide—hematologic cancer	0.00122	0.00748	CbGbCtD
Dexamethasone—NR3C1—Betamethasone—hematologic cancer	0.00121	0.00746	CbGbCtD
Dexamethasone—Fluocinonide—Triamcinolone—hematologic cancer	0.00121	0.00952	CrCrCtD
Dexamethasone—Prednicarbate—Triamcinolone—hematologic cancer	0.00121	0.00952	CrCrCtD
Dexamethasone—Testolactone—Triamcinolone—hematologic cancer	0.00121	0.00952	CrCrCtD
Dexamethasone—Clocortolone—Triamcinolone—hematologic cancer	0.00121	0.00952	CrCrCtD
Dexamethasone—Beclomethasone—Triamcinolone—hematologic cancer	0.00121	0.00952	CrCrCtD
Dexamethasone—ABCG2—Cladribine—hematologic cancer	0.00121	0.00741	CbGbCtD
Dexamethasone—PGR—ovarian follicle—hematologic cancer	0.0012	0.0757	CbGeAlD
Dexamethasone—Fluocortolone—Betamethasone—hematologic cancer	0.0012	0.00946	CrCrCtD
Dexamethasone—NR3C1—Prednisolone—hematologic cancer	0.0012	0.00736	CbGbCtD
Dexamethasone—Fluocortolone—Triamcinolone—hematologic cancer	0.00117	0.00924	CrCrCtD
Dexamethasone—Alclometasone—Betamethasone—hematologic cancer	0.00117	0.0092	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00117	0.0092	CrCrCtD
Dexamethasone—Prednicarbate—Prednisone—hematologic cancer	0.00115	0.00903	CrCrCtD
Dexamethasone—Testolactone—Prednisone—hematologic cancer	0.00115	0.00903	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00114	0.00899	CrCrCtD
Dexamethasone—Alclometasone—Triamcinolone—hematologic cancer	0.00114	0.00899	CrCrCtD
Dexamethasone—Amcinonide—Betamethasone—hematologic cancer	0.00114	0.00895	CrCrCtD
Dexamethasone—Fluoxymesterone—Betamethasone—hematologic cancer	0.00114	0.00895	CrCrCtD
Dexamethasone—Budesonide—Betamethasone—hematologic cancer	0.00114	0.00895	CrCrCtD
Dexamethasone—NR3C1—Prednisone—hematologic cancer	0.00113	0.00696	CbGbCtD
Dexamethasone—Prednicarbate—Prednisolone—hematologic cancer	0.00112	0.00882	CrCrCtD
Dexamethasone—Testolactone—Prednisolone—hematologic cancer	0.00112	0.00882	CrCrCtD
Dexamethasone—Clocortolone—Prednisolone—hematologic cancer	0.00112	0.00882	CrCrCtD
Dexamethasone—Beclomethasone—Prednisolone—hematologic cancer	0.00112	0.00882	CrCrCtD
Dexamethasone—Fluocortolone—Prednisone—hematologic cancer	0.00112	0.00877	CrCrCtD
Dexamethasone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00111	0.00875	CrCrCtD
Dexamethasone—Budesonide—Triamcinolone—hematologic cancer	0.00111	0.00875	CrCrCtD
Dexamethasone—Amcinonide—Triamcinolone—hematologic cancer	0.00111	0.00875	CrCrCtD
Dexamethasone—ABCG2—Imatinib—hematologic cancer	0.00111	0.00682	CbGbCtD
Dexamethasone—Diflorasone—Betamethasone—hematologic cancer	0.00111	0.00872	CrCrCtD
Dexamethasone—Flunisolide—Betamethasone—hematologic cancer	0.00111	0.00872	CrCrCtD
Dexamethasone—Clobetasol propionate—Betamethasone—hematologic cancer	0.00111	0.00872	CrCrCtD
Dexamethasone—Desonide—Betamethasone—hematologic cancer	0.00111	0.00872	CrCrCtD
Dexamethasone—Prednisone—Betamethasone—hematologic cancer	0.00111	0.00872	CrCrCtD
Dexamethasone—Fludrocortisone—Betamethasone—hematologic cancer	0.00111	0.00872	CrCrCtD
Dexamethasone—Fluocortolone—Prednisolone—hematologic cancer	0.00109	0.00856	CrCrCtD
Dexamethasone—Alclometasone—Prednisone—hematologic cancer	0.00108	0.00853	CrCrCtD
Dexamethasone—CYP19A1—ovarian follicle—hematologic cancer	0.00108	0.0681	CbGeAlD
Dexamethasone—Flunisolide—Triamcinolone—hematologic cancer	0.00108	0.00852	CrCrCtD
Dexamethasone—Fludrocortisone—Triamcinolone—hematologic cancer	0.00108	0.00852	CrCrCtD
Dexamethasone—Desonide—Triamcinolone—hematologic cancer	0.00108	0.00852	CrCrCtD
Dexamethasone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00108	0.00852	CrCrCtD
Dexamethasone—Prednisone—Triamcinolone—hematologic cancer	0.00108	0.00852	CrCrCtD
Dexamethasone—Diflorasone—Triamcinolone—hematologic cancer	0.00108	0.00852	CrCrCtD
Dexamethasone—Paramethasone—Betamethasone—hematologic cancer	0.00108	0.0085	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00106	0.00833	CrCrCtD
Dexamethasone—Alclometasone—Prednisolone—hematologic cancer	0.00106	0.00833	CrCrCtD
Dexamethasone—Paramethasone—Triamcinolone—hematologic cancer	0.00106	0.00831	CrCrCtD
Dexamethasone—Amcinonide—Prednisone—hematologic cancer	0.00106	0.0083	CrCrCtD
Dexamethasone—Budesonide—Prednisone—hematologic cancer	0.00106	0.0083	CrCrCtD
Dexamethasone—Desoximetasone—Betamethasone—hematologic cancer	0.00105	0.0083	CrCrCtD
Dexamethasone—CYP1A1—Dacarbazine—hematologic cancer	0.00105	0.00643	CbGbCtD
Dexamethasone—SLCO1A2—Prednisolone—hematologic cancer	0.00103	0.00635	CbGbCtD
Dexamethasone—Desoximetasone—Triamcinolone—hematologic cancer	0.00103	0.00811	CrCrCtD
Dexamethasone—Amcinonide—Prednisolone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Budesonide—Prednisolone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Fluoxymesterone—Prednisolone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Triamcinolone—Betamethasone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Mometasone—Betamethasone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Loteprednol—Betamethasone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Fluorometholone—Betamethasone—hematologic cancer	0.00103	0.0081	CrCrCtD
Dexamethasone—Flunisolide—Prednisone—hematologic cancer	0.00103	0.00809	CrCrCtD
Dexamethasone—Desonide—Prednisone—hematologic cancer	0.00103	0.00809	CrCrCtD
Dexamethasone—Clobetasol propionate—Prednisone—hematologic cancer	0.00103	0.00809	CrCrCtD
Dexamethasone—Fludrocortisone—Prednisone—hematologic cancer	0.00103	0.00809	CrCrCtD
Dexamethasone—Diflorasone—Prednisone—hematologic cancer	0.00103	0.00809	CrCrCtD
Dexamethasone—ABCG2—Nilotinib—hematologic cancer	0.00101	0.0062	CbGbCtD
Dexamethasone—Rimexolone—Betamethasone—hematologic cancer	0.00101	0.00791	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00101	0.00791	CrCrCtD
Dexamethasone—Mometasone—Triamcinolone—hematologic cancer	0.00101	0.00791	CrCrCtD
Dexamethasone—Loteprednol—Triamcinolone—hematologic cancer	0.00101	0.00791	CrCrCtD
Dexamethasone—Fluorometholone—Triamcinolone—hematologic cancer	0.00101	0.00791	CrCrCtD
Dexamethasone—Clobetasol propionate—Prednisolone—hematologic cancer	0.001	0.00789	CrCrCtD
Dexamethasone—Flunisolide—Prednisolone—hematologic cancer	0.001	0.00789	CrCrCtD
Dexamethasone—Prednisone—Prednisolone—hematologic cancer	0.001	0.00789	CrCrCtD
Dexamethasone—Desonide—Prednisolone—hematologic cancer	0.001	0.00789	CrCrCtD
Dexamethasone—Diflorasone—Prednisolone—hematologic cancer	0.001	0.00789	CrCrCtD
Dexamethasone—Fludrocortisone—Prednisolone—hematologic cancer	0.001	0.00789	CrCrCtD
Dexamethasone—Paramethasone—Prednisone—hematologic cancer	0.001	0.00788	CrCrCtD
Dexamethasone—PTGS2—Triamcinolone—hematologic cancer	0.000999	0.00614	CbGbCtD
Dexamethasone—Betamethasone—Triamcinolone—hematologic cancer	0.000983	0.00773	CrCrCtD
Dexamethasone—Rimexolone—Triamcinolone—hematologic cancer	0.000983	0.00773	CrCrCtD
Dexamethasone—Paramethasone—Prednisolone—hematologic cancer	0.000978	0.0077	CrCrCtD
Dexamethasone—Desoximetasone—Prednisone—hematologic cancer	0.000978	0.00769	CrCrCtD
Dexamethasone—SLCO1A2—Prednisone—hematologic cancer	0.000975	0.00599	CbGbCtD
Dexamethasone—Methylprednisolone—Betamethasone—hematologic cancer	0.000962	0.00757	CrCrCtD
Dexamethasone—Fluorometholone—Prednisone—hematologic cancer	0.000955	0.00751	CrCrCtD
Dexamethasone—Loteprednol—Prednisone—hematologic cancer	0.000955	0.00751	CrCrCtD
Dexamethasone—Mometasone—Prednisone—hematologic cancer	0.000955	0.00751	CrCrCtD
Dexamethasone—Triamcinolone—Prednisone—hematologic cancer	0.000955	0.00751	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.000955	0.00751	CrCrCtD
Dexamethasone—Desoximetasone—Prednisolone—hematologic cancer	0.000954	0.00751	CrCrCtD
Dexamethasone—Prednisolone—Betamethasone—hematologic cancer	0.000942	0.00741	CrCrCtD
Dexamethasone—Methylprednisolone—Triamcinolone—hematologic cancer	0.00094	0.0074	CrCrCtD
Dexamethasone—CYP2E1—Thalidomide—hematologic cancer	0.00094	0.00578	CbGbCtD
Dexamethasone—Betamethasone—Prednisone—hematologic cancer	0.000933	0.00734	CrCrCtD
Dexamethasone—Rimexolone—Prednisone—hematologic cancer	0.000933	0.00734	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.000932	0.00733	CrCrCtD
Dexamethasone—Mometasone—Prednisolone—hematologic cancer	0.000932	0.00733	CrCrCtD
Dexamethasone—Loteprednol—Prednisolone—hematologic cancer	0.000932	0.00733	CrCrCtD
Dexamethasone—Triamcinolone—Prednisolone—hematologic cancer	0.000932	0.00733	CrCrCtD
Dexamethasone—Fluorometholone—Prednisolone—hematologic cancer	0.000932	0.00733	CrCrCtD
Dexamethasone—Prednisolone—Triamcinolone—hematologic cancer	0.00092	0.00724	CrCrCtD
Dexamethasone—CYP2C9—Bexarotene—hematologic cancer	0.000917	0.00564	CbGbCtD
Dexamethasone—Rimexolone—Prednisolone—hematologic cancer	0.00091	0.00716	CrCrCtD
Dexamethasone—Betamethasone—Prednisolone—hematologic cancer	0.00091	0.00716	CrCrCtD
Dexamethasone—Hydrocortisone—Betamethasone—hematologic cancer	0.000904	0.00711	CrCrCtD
Dexamethasone—Methylprednisolone—Prednisone—hematologic cancer	0.000892	0.00702	CrCrCtD
Dexamethasone—ABCG2—Dasatinib—hematologic cancer	0.00089	0.00548	CbGbCtD
Dexamethasone—ABCB1—Lenalidomide—hematologic cancer	0.00089	0.00547	CbGbCtD
Dexamethasone—Hydrocortisone—Triamcinolone—hematologic cancer	0.000883	0.00695	CrCrCtD
Dexamethasone—ABCG2—Mitoxantrone—hematologic cancer	0.00088	0.00541	CbGbCtD
Dexamethasone—Prednisolone—Prednisone—hematologic cancer	0.000873	0.00687	CrCrCtD
Dexamethasone—Methylprednisolone—Prednisolone—hematologic cancer	0.000871	0.00685	CrCrCtD
Dexamethasone—CYP3A7—Ifosfamide—hematologic cancer	0.000857	0.00527	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.000857	0.00527	CbGbCtD
Dexamethasone—PTGS2—Betamethasone—hematologic cancer	0.000857	0.00527	CbGbCtD
Dexamethasone—Hydrocortisone—Prednisone—hematologic cancer	0.000838	0.0066	CrCrCtD
Dexamethasone—CYP2A6—Prednisolone—hematologic cancer	0.000836	0.00514	CbGbCtD
Dexamethasone—CYP1A1—Dasatinib—hematologic cancer	0.000822	0.00505	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.000819	0.00504	CbGbCtD
Dexamethasone—CYP3A7—Imatinib—hematologic cancer	0.000819	0.00504	CbGbCtD
Dexamethasone—Hydrocortisone—Prednisolone—hematologic cancer	0.000818	0.00644	CrCrCtD
Dexamethasone—CYP2B6—Ifosfamide—hematologic cancer	0.000816	0.00502	CbGbCtD
Dexamethasone—CYP2E1—Dacarbazine—hematologic cancer	0.000808	0.00497	CbGbCtD
Dexamethasone—CYP2C8—Bortezomib—hematologic cancer	0.000806	0.00496	CbGbCtD
Dexamethasone—CYP3A5—Daunorubicin—hematologic cancer	0.000802	0.00493	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—hematologic cancer	0.000796	0.00489	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—hematologic cancer	0.000796	0.00489	CbGbCtD
Dexamethasone—CYP2D6—Lomustine—hematologic cancer	0.00078	0.0048	CbGbCtD
Dexamethasone—ABCC2—Irinotecan—hematologic cancer	0.000766	0.00471	CbGbCtD
Dexamethasone—CYP2C9—Idarubicin—hematologic cancer	0.00076	0.00467	CbGbCtD
Dexamethasone—CYP3A5—Thalidomide—hematologic cancer	0.00073	0.00449	CbGbCtD
Dexamethasone—CYP2B6—Nilotinib—hematologic cancer	0.000709	0.00436	CbGbCtD
Dexamethasone—CYP3A5—Teniposide—hematologic cancer	0.000697	0.00428	CbGbCtD
Dexamethasone—CYP2D6—Idarubicin—hematologic cancer	0.000695	0.00427	CbGbCtD
Dexamethasone—ABCG2—Irinotecan—hematologic cancer	0.000693	0.00426	CbGbCtD
Dexamethasone—ABCC2—Vinblastine—hematologic cancer	0.000681	0.00419	CbGbCtD
Dexamethasone—CYP2C19—Bortezomib—hematologic cancer	0.000676	0.00416	CbGbCtD
Dexamethasone—ABCC2—Vincristine—hematologic cancer	0.00067	0.00412	CbGbCtD
Dexamethasone—CYP3A5—Ifosfamide—hematologic cancer	0.000643	0.00395	CbGbCtD
Dexamethasone—CYP2E1—Mitoxantrone—hematologic cancer	0.000627	0.00386	CbGbCtD
Dexamethasone—ABCC2—Cisplatin—hematologic cancer	0.000624	0.00384	CbGbCtD
Dexamethasone—CYP2C8—Ifosfamide—hematologic cancer	0.000618	0.0038	CbGbCtD
Dexamethasone—PTGS2—Cisplatin—hematologic cancer	0.000617	0.00379	CbGbCtD
Dexamethasone—CYP3A5—Imatinib—hematologic cancer	0.000614	0.00378	CbGbCtD
Dexamethasone—ABCC2—Etoposide—hematologic cancer	0.000614	0.00377	CbGbCtD
Dexamethasone—PTGS2—Etoposide—hematologic cancer	0.000606	0.00373	CbGbCtD
Dexamethasone—ABCG2—Vincristine—hematologic cancer	0.000605	0.00372	CbGbCtD
Dexamethasone—PTGS2—ovarian follicle—hematologic cancer	0.000601	0.0378	CbGeAlD
Dexamethasone—CYP2D6—Hydroxyurea—hematologic cancer	0.000591	0.00363	CbGbCtD
Dexamethasone—CYP2C19—Thalidomide—hematologic cancer	0.000589	0.00362	CbGbCtD
Dexamethasone—ABCG2—Cisplatin—hematologic cancer	0.000565	0.00347	CbGbCtD
Dexamethasone—CYP2C9—Bortezomib—hematologic cancer	0.000562	0.00346	CbGbCtD
Dexamethasone—CYP2C19—Teniposide—hematologic cancer	0.000562	0.00346	CbGbCtD
Dexamethasone—ABCG2—Etoposide—hematologic cancer	0.000555	0.00341	CbGbCtD
Dexamethasone—CYP2C8—Nilotinib—hematologic cancer	0.000537	0.0033	CbGbCtD
Dexamethasone—CYP3A4—Bexarotene—hematologic cancer	0.000533	0.00328	CbGbCtD
Dexamethasone—ABCB1—Daunorubicin—hematologic cancer	0.000522	0.00321	CbGbCtD
Dexamethasone—CYP2C19—Ifosfamide—hematologic cancer	0.000519	0.00319	CbGbCtD
Dexamethasone—CYP2D6—Bortezomib—hematologic cancer	0.000514	0.00316	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.000511	0.00314	CbGbCtD
Dexamethasone—CYP3A7—Irinotecan—hematologic cancer	0.000511	0.00314	CbGbCtD
Dexamethasone—ABCB1—Alitretinoin—hematologic cancer	0.000511	0.00314	CbGbCtD
Dexamethasone—CYP3A4—Lomustine—hematologic cancer	0.000496	0.00305	CbGbCtD
Dexamethasone—CYP3A4—Busulfan—hematologic cancer	0.000496	0.00305	CbGbCtD
Dexamethasone—CYP2C19—Imatinib—hematologic cancer	0.000495	0.00305	CbGbCtD
Dexamethasone—CYP3A5—Dasatinib—hematologic cancer	0.000493	0.00303	CbGbCtD
Dexamethasone—CYP2C9—Thalidomide—hematologic cancer	0.00049	0.00301	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—hematologic cancer	0.000489	0.00301	CbGbCtD
Dexamethasone—CYP2B6—Irinotecan—hematologic cancer	0.000487	0.00299	CbGbCtD
Dexamethasone—CYP2C9—Teniposide—hematologic cancer	0.000467	0.00287	CbGbCtD
Dexamethasone—CYP3A7—Vincristine—hematologic cancer	0.000447	0.00275	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.000447	0.00275	CbGbCtD
Dexamethasone—CYP3A4—Thiotepa—hematologic cancer	0.000442	0.00272	CbGbCtD
Dexamethasone—CYP2C9—Ifosfamide—hematologic cancer	0.000431	0.00265	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—hematologic cancer	0.000418	0.00257	CbGbCtD
Dexamethasone—CYP2C9—Imatinib—hematologic cancer	0.000412	0.00253	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—hematologic cancer	0.000405	0.00249	CbGbCtD
Dexamethasone—ABCB1—Imatinib—hematologic cancer	0.0004	0.00246	CbGbCtD
Dexamethasone—CYP2B6—Cisplatin—hematologic cancer	0.000397	0.00244	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—hematologic cancer	0.000395	0.00243	CbGbCtD
Dexamethasone—CYP3A5—Irinotecan—hematologic cancer	0.000384	0.00236	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—hematologic cancer	0.000378	0.00233	CbGbCtD
Dexamethasone—CYP2D6—Imatinib—hematologic cancer	0.000377	0.00232	CbGbCtD
Dexamethasone—CYP2C9—Nilotinib—hematologic cancer	0.000374	0.0023	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—hematologic cancer	0.000366	0.00225	CbGbCtD
Dexamethasone—ABCB1—Nilotinib—hematologic cancer	0.000363	0.00223	CbGbCtD
Dexamethasone—ABCB1—Vinorelbine—hematologic cancer	0.00036	0.00222	CbGbCtD
Dexamethasone—CYP3A4—Methoxsalen—hematologic cancer	0.000344	0.00211	CbGbCtD
Dexamethasone—CYP2D6—Nilotinib—hematologic cancer	0.000342	0.0021	CbGbCtD
Dexamethasone—CYP2D6—Vinorelbine—hematologic cancer	0.000339	0.00209	CbGbCtD
Dexamethasone—NR0B1—gonad—hematologic cancer	0.000337	0.0212	CbGeAlD
Dexamethasone—CYP3A5—Vincristine—hematologic cancer	0.000335	0.00206	CbGbCtD
Dexamethasone—CYP3A4—Bortezomib—hematologic cancer	0.000327	0.00201	CbGbCtD
Dexamethasone—CYP2C19—Prednisone—hematologic cancer	0.000326	0.00201	CbGbCtD
Dexamethasone—ABCB1—Dasatinib—hematologic cancer	0.000321	0.00197	CbGbCtD
Dexamethasone—ABCB1—Mitoxantrone—hematologic cancer	0.000317	0.00195	CbGbCtD
Dexamethasone—PLA2G1B—hematopoietic system—hematologic cancer	0.000316	0.0198	CbGeAlD
Dexamethasone—CYP3A4—Daunorubicin—hematologic cancer	0.000313	0.00192	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—hematologic cancer	0.000307	0.00189	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—hematologic cancer	0.000295	0.00182	CbGbCtD
Dexamethasone—CYP3A43—testis—hematologic cancer	0.000293	0.0184	CbGeAlD
Dexamethasone—ABCB1—Betamethasone—hematologic cancer	0.000283	0.00174	CbGbCtD
Dexamethasone—ABCB1—Gemcitabine—hematologic cancer	0.00028	0.00172	CbGbCtD
Dexamethasone—ABCB1—Prednisolone—hematologic cancer	0.000279	0.00172	CbGbCtD
Dexamethasone—CYP3A4—Cytarabine—hematologic cancer	0.000276	0.0017	CbGbCtD
Dexamethasone—CYP3A4—Teniposide—hematologic cancer	0.000272	0.00167	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—hematologic cancer	0.000266	0.00164	CbGbCtD
Dexamethasone—ABCB1—Prednisone—hematologic cancer	0.000263	0.00162	CbGbCtD
Dexamethasone—NR0B1—lung—hematologic cancer	0.000257	0.0162	CbGeAlD
Dexamethasone—CYP3A4—Ifosfamide—hematologic cancer	0.000251	0.00154	CbGbCtD
Dexamethasone—ABCB1—Irinotecan—hematologic cancer	0.00025	0.00154	CbGbCtD
Dexamethasone—NR0B1—testis—hematologic cancer	0.000243	0.0153	CbGeAlD
Dexamethasone—ANXA1—hematopoietic system—hematologic cancer	0.000241	0.0152	CbGeAlD
Dexamethasone—CYP3A4—Imatinib—hematologic cancer	0.00024	0.00147	CbGbCtD
Dexamethasone—CYP3A4—Ruxolitinib—hematologic cancer	0.000226	0.00139	CbGbCtD
Dexamethasone—ABCB1—Vinblastine—hematologic cancer	0.000222	0.00137	CbGbCtD
Dexamethasone—ABCB1—Vincristine—hematologic cancer	0.000218	0.00134	CbGbCtD
Dexamethasone—CYP3A4—Nilotinib—hematologic cancer	0.000218	0.00134	CbGbCtD
Dexamethasone—CYP3A4—Vinorelbine—hematologic cancer	0.000216	0.00133	CbGbCtD
Dexamethasone—CYP2C9—Cisplatin—hematologic cancer	0.00021	0.00129	CbGbCtD
Dexamethasone—CYP2D6—Vinblastine—hematologic cancer	0.000209	0.00129	CbGbCtD
Dexamethasone—PLA2G1B—blood—hematologic cancer	0.000209	0.0131	CbGeAlD
Dexamethasone—ABCB1—Cisplatin—hematologic cancer	0.000204	0.00125	CbGbCtD
Dexamethasone—CYP11A1—hematopoietic system—hematologic cancer	0.000201	0.0127	CbGeAlD
Dexamethasone—ABCB1—Etoposide—hematologic cancer	0.0002	0.00123	CbGbCtD
Dexamethasone—CYP3A4—Triamcinolone—hematologic cancer	0.000197	0.00121	CbGbCtD
Dexamethasone—CYP3A4—Dasatinib—hematologic cancer	0.000192	0.00118	CbGbCtD
Dexamethasone—CYP3A4—Mitoxantrone—hematologic cancer	0.00019	0.00117	CbGbCtD
Dexamethasone—ANXA1—gonad—hematologic cancer	0.000184	0.0115	CbGeAlD
Dexamethasone—PLA2G1B—lung—hematologic cancer	0.000183	0.0115	CbGeAlD
Dexamethasone—PLA2G1B—testis—hematologic cancer	0.000173	0.0109	CbGeAlD
Dexamethasone—CYP3A4—Betamethasone—hematologic cancer	0.000169	0.00104	CbGbCtD
Dexamethasone—CYP3A4—Prednisolone—hematologic cancer	0.000167	0.00103	CbGbCtD
Dexamethasone—CYP17A1—gonad—hematologic cancer	0.000164	0.0103	CbGeAlD
Dexamethasone—ANXA1—blood—hematologic cancer	0.00016	0.0101	CbGeAlD
Dexamethasone—CYP3A4—Prednisone—hematologic cancer	0.000158	0.00097	CbGbCtD
Dexamethasone—NR3C2—hematopoietic system—hematologic cancer	0.000156	0.00983	CbGeAlD
Dexamethasone—ANXA1—bone marrow—hematologic cancer	0.000155	0.00973	CbGeAlD
Dexamethasone—CYP11A1—gonad—hematologic cancer	0.000153	0.00962	CbGeAlD
Dexamethasone—CYP3A4—Irinotecan—hematologic cancer	0.00015	0.00092	CbGbCtD
Dexamethasone—PGR—hematopoietic system—hematologic cancer	0.000145	0.00914	CbGeAlD
Dexamethasone—ANXA1—lung—hematologic cancer	0.00014	0.00881	CbGeAlD
Dexamethasone—ABCB1—Doxorubicin—hematologic cancer	0.000136	0.000839	CbGbCtD
Dexamethasone—ABCB11—testis—hematologic cancer	0.000135	0.00846	CbGeAlD
Dexamethasone—SLCO1A2—hematopoietic system—hematologic cancer	0.000134	0.00842	CbGeAlD
Dexamethasone—CYP11A1—blood—hematologic cancer	0.000133	0.00838	CbGeAlD
Dexamethasone—CYP3A4—Vinblastine—hematologic cancer	0.000133	0.000818	CbGbCtD
Dexamethasone—ANXA1—testis—hematologic cancer	0.000132	0.00832	CbGeAlD
Dexamethasone—ABCB1—Methotrexate—hematologic cancer	0.000132	0.000813	CbGbCtD
Dexamethasone—CYP3A4—Vincristine—hematologic cancer	0.000131	0.000804	CbGbCtD
Dexamethasone—CYP19A1—hematopoietic system—hematologic cancer	0.000131	0.00822	CbGeAlD
Dexamethasone—CYP2D6—Doxorubicin—hematologic cancer	0.000129	0.00079	CbGbCtD
Dexamethasone—CYP1B1—hematopoietic system—hematologic cancer	0.000122	0.00769	CbGeAlD
Dexamethasone—CYP3A4—Etoposide—hematologic cancer	0.00012	0.000737	CbGbCtD
Dexamethasone—CYP17A1—testis—hematologic cancer	0.000119	0.00745	CbGeAlD
Dexamethasone—CYP11A1—testis—hematologic cancer	0.00011	0.00693	CbGeAlD
Dexamethasone—CYP2C19—hematopoietic system—hematologic cancer	0.000107	0.00674	CbGeAlD
Dexamethasone—NR3C2—blood—hematologic cancer	0.000104	0.00651	CbGeAlD
Dexamethasone—CYP19A1—gonad—hematologic cancer	9.94e-05	0.00625	CbGeAlD
Dexamethasone—CYP2A6—lung—hematologic cancer	9.69e-05	0.00609	CbGeAlD
Dexamethasone—PGR—blood—hematologic cancer	9.63e-05	0.00605	CbGeAlD
Dexamethasone—ANXA1—lymph node—hematologic cancer	9.59e-05	0.00603	CbGeAlD
Dexamethasone—CYP2C8—hematopoietic system—hematologic cancer	9.36e-05	0.00589	CbGeAlD
Dexamethasone—CYP1B1—gonad—hematologic cancer	9.29e-05	0.00584	CbGeAlD
Dexamethasone—NR3C2—lung—hematologic cancer	9.08e-05	0.00571	CbGeAlD
Dexamethasone—CYP19A1—blood—hematologic cancer	8.66e-05	0.00545	CbGeAlD
Dexamethasone—CYP1A1—hematopoietic system—hematologic cancer	8.64e-05	0.00543	CbGeAlD
Dexamethasone—CYP17A1—lymph node—hematologic cancer	8.59e-05	0.0054	CbGeAlD
Dexamethasone—NR3C2—testis—hematologic cancer	8.57e-05	0.00539	CbGeAlD
Dexamethasone—CYP3A5—hematopoietic system—hematologic cancer	8.45e-05	0.00531	CbGeAlD
Dexamethasone—PGR—lung—hematologic cancer	8.44e-05	0.00531	CbGeAlD
Dexamethasone—CYP2B6—hematopoietic system—hematologic cancer	8.4e-05	0.00528	CbGeAlD
Dexamethasone—NR3C1—hematopoietic system—hematologic cancer	8.38e-05	0.00527	CbGeAlD
Dexamethasone—CYP2C9—hematopoietic system—hematologic cancer	8.32e-05	0.00523	CbGeAlD
Dexamethasone—ABCC2—blood—hematologic cancer	8.27e-05	0.0052	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—hematologic cancer	8.17e-05	0.000503	CbGbCtD
Dexamethasone—CYP1B1—blood—hematologic cancer	8.1e-05	0.00509	CbGeAlD
Dexamethasone—CYP11A1—lymph node—hematologic cancer	8e-05	0.00503	CbGeAlD
Dexamethasone—PGR—testis—hematologic cancer	7.96e-05	0.00501	CbGeAlD
Dexamethasone—CYP2E1—hematopoietic system—hematologic cancer	7.88e-05	0.00495	CbGeAlD
Dexamethasone—SLCO1A2—lung—hematologic cancer	7.78e-05	0.00489	CbGeAlD
Dexamethasone—SLCO1A2—testis—hematologic cancer	7.34e-05	0.00462	CbGeAlD
Dexamethasone—PTGS2—hematopoietic system—hematologic cancer	7.26e-05	0.00456	CbGeAlD
Dexamethasone—CYP19A1—testis—hematologic cancer	7.17e-05	0.00451	CbGeAlD
Dexamethasone—CYP2C19—blood—hematologic cancer	7.11e-05	0.00447	CbGeAlD
Dexamethasone—CYP1B1—lung—hematologic cancer	7.1e-05	0.00446	CbGeAlD
Dexamethasone—ABCC2—testis—hematologic cancer	6.84e-05	0.0043	CbGeAlD
Dexamethasone—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	6.81e-05	0.315	CbGdCrCtD
Dexamethasone—CYP1B1—testis—hematologic cancer	6.7e-05	0.00421	CbGeAlD
Dexamethasone—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	6.65e-05	0.308	CbGdCrCtD
Dexamethasone—CYP2B6—gonad—hematologic cancer	6.39e-05	0.00401	CbGeAlD
Dexamethasone—NR3C1—gonad—hematologic cancer	6.38e-05	0.00401	CbGeAlD
Dexamethasone—CYP3A4—hematopoietic system—hematologic cancer	6.34e-05	0.00399	CbGeAlD
Dexamethasone—CYP2D6—hematopoietic system—hematologic cancer	6.24e-05	0.00392	CbGeAlD
Dexamethasone—NR3C2—lymph node—hematologic cancer	6.21e-05	0.0039	CbGeAlD
Dexamethasone—CYP2C8—blood—hematologic cancer	6.2e-05	0.0039	CbGeAlD
Dexamethasone—ABCG2—blood—hematologic cancer	6.03e-05	0.00379	CbGeAlD
Dexamethasone—ABCG2—bone marrow—hematologic cancer	5.84e-05	0.00367	CbGeAlD
Dexamethasone—PGR—lymph node—hematologic cancer	5.77e-05	0.00363	CbGeAlD
Dexamethasone—CYP1A1—blood—hematologic cancer	5.73e-05	0.0036	CbGeAlD
Dexamethasone—CYP3A5—blood—hematologic cancer	5.6e-05	0.00352	CbGeAlD
Dexamethasone—CYP2B6—blood—hematologic cancer	5.56e-05	0.0035	CbGeAlD
Dexamethasone—NR3C1—blood—hematologic cancer	5.56e-05	0.00349	CbGeAlD
Dexamethasone—CYP2C9—blood—hematologic cancer	5.51e-05	0.00346	CbGeAlD
Dexamethasone—NR3C1—bone marrow—hematologic cancer	5.38e-05	0.00338	CbGeAlD
Dexamethasone—ABCG2—lung—hematologic cancer	5.29e-05	0.00332	CbGeAlD
Dexamethasone—CYP2E1—blood—hematologic cancer	5.22e-05	0.00328	CbGeAlD
Dexamethasone—CYP19A1—lymph node—hematologic cancer	5.19e-05	0.00327	CbGeAlD
Dexamethasone—CYP2C8—testis—hematologic cancer	5.13e-05	0.00323	CbGeAlD
Dexamethasone—CYP1A1—lung—hematologic cancer	5.02e-05	0.00316	CbGeAlD
Dexamethasone—ABCG2—testis—hematologic cancer	4.99e-05	0.00314	CbGeAlD
Dexamethasone—ABCC2—lymph node—hematologic cancer	4.96e-05	0.00312	CbGeAlD
Dexamethasone—CYP3A5—lung—hematologic cancer	4.91e-05	0.00309	CbGeAlD
Dexamethasone—CYP2B6—lung—hematologic cancer	4.88e-05	0.00307	CbGeAlD
Dexamethasone—NR3C1—lung—hematologic cancer	4.87e-05	0.00306	CbGeAlD
Dexamethasone—CYP1B1—lymph node—hematologic cancer	4.86e-05	0.00305	CbGeAlD
Dexamethasone—PTGS2—blood—hematologic cancer	4.81e-05	0.00302	CbGeAlD
Dexamethasone—PTGS2—bone marrow—hematologic cancer	4.65e-05	0.00292	CbGeAlD
Dexamethasone—CYP2B6—testis—hematologic cancer	4.6e-05	0.00289	CbGeAlD
Dexamethasone—NR3C1—testis—hematologic cancer	4.6e-05	0.00289	CbGeAlD
Dexamethasone—CYP2E1—lung—hematologic cancer	4.58e-05	0.00288	CbGeAlD
Dexamethasone—ABCB1—hematopoietic system—hematologic cancer	4.49e-05	0.00282	CbGeAlD
Dexamethasone—CYP2E1—testis—hematologic cancer	4.32e-05	0.00272	CbGeAlD
Dexamethasone—PTGS2—lung—hematologic cancer	4.21e-05	0.00265	CbGeAlD
Dexamethasone—CYP3A4—blood—hematologic cancer	4.2e-05	0.00264	CbGeAlD
Dexamethasone—CYP2D6—blood—hematologic cancer	4.13e-05	0.0026	CbGeAlD
Dexamethasone—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	4.11e-05	0.19	CbGdCrCtD
Dexamethasone—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	4.01e-05	0.186	CbGdCrCtD
Dexamethasone—ABCG2—lymph node—hematologic cancer	3.62e-05	0.00227	CbGeAlD
Dexamethasone—Difluprednate—NR3C1—hematologic cancer	3.48e-05	0.0398	CrCbGaD
Dexamethasone—CYP1A1—lymph node—hematologic cancer	3.43e-05	0.00216	CbGeAlD
Dexamethasone—CYP2D6—testis—hematologic cancer	3.42e-05	0.00215	CbGeAlD
Dexamethasone—ABCB1—gonad—hematologic cancer	3.41e-05	0.00215	CbGeAlD
Dexamethasone—Clocortolone—NR3C1—hematologic cancer	3.37e-05	0.0386	CrCbGaD
Dexamethasone—Prednicarbate—NR3C1—hematologic cancer	3.37e-05	0.0386	CrCbGaD
Dexamethasone—NR3C1—lymph node—hematologic cancer	3.33e-05	0.00209	CbGeAlD
Dexamethasone—Desonide—NR3C1—hematologic cancer	3.19e-05	0.0365	CrCbGaD
Dexamethasone—Diflorasone—NR3C1—hematologic cancer	3.19e-05	0.0365	CrCbGaD
Dexamethasone—Desoximetasone—NR3C1—hematologic cancer	3.11e-05	0.0356	CrCbGaD
Dexamethasone—Loteprednol—NR3C1—hematologic cancer	3.08e-05	0.0352	CrCbGaD
Dexamethasone—Fludrocortisone—AR—hematologic cancer	3.03e-05	0.0347	CrCbGaD
Dexamethasone—ABCB1—blood—hematologic cancer	2.97e-05	0.00187	CbGeAlD
Dexamethasone—PTGS2—lymph node—hematologic cancer	2.88e-05	0.00181	CbGeAlD
Dexamethasone—ABCB1—bone marrow—hematologic cancer	2.88e-05	0.00181	CbGeAlD
Dexamethasone—Flurandrenolide—NR3C1—hematologic cancer	2.73e-05	0.0312	CrCbGaD
Dexamethasone—Flumethasone Pivalate—NR3C1—hematologic cancer	2.68e-05	0.0307	CrCbGaD
Dexamethasone—Halobetasol Propionate—NR3C1—hematologic cancer	2.64e-05	0.0302	CrCbGaD
Dexamethasone—ABCB1—lung—hematologic cancer	2.61e-05	0.00164	CbGeAlD
Dexamethasone—Fluoxymesterone—AR—hematologic cancer	2.5e-05	0.0287	CrCbGaD
Dexamethasone—ABCB1—testis—hematologic cancer	2.46e-05	0.00155	CbGeAlD
Dexamethasone—Budesonide—NR3C1—hematologic cancer	2.45e-05	0.0281	CrCbGaD
Dexamethasone—Amcinonide—NR3C1—hematologic cancer	2.45e-05	0.0281	CrCbGaD
Dexamethasone—Fluticasone furoate—NR3C1—hematologic cancer	2.4e-05	0.0275	CrCbGaD
Dexamethasone—Mometasone—NR3C1—hematologic cancer	2.33e-05	0.0267	CrCbGaD
Dexamethasone—Rimexolone—NR3C1—hematologic cancer	2.3e-05	0.0264	CrCbGaD
Dexamethasone—Beclomethasone—NR3C1—hematologic cancer	2.17e-05	0.0249	CrCbGaD
Dexamethasone—Fluocinonide—NR3C1—hematologic cancer	2.17e-05	0.0249	CrCbGaD
Dexamethasone—Alclometasone—NR3C1—hematologic cancer	2.11e-05	0.0242	CrCbGaD
Dexamethasone—Fluocinolone Acetonide—NR3C1—hematologic cancer	2.11e-05	0.0242	CrCbGaD
Dexamethasone—Fludrocortisone—NR3C1—hematologic cancer	2.06e-05	0.0235	CrCbGaD
Dexamethasone—Flunisolide—NR3C1—hematologic cancer	2.06e-05	0.0235	CrCbGaD
Dexamethasone—Clobetasol propionate—NR3C1—hematologic cancer	2.06e-05	0.0235	CrCbGaD
Dexamethasone—Paramethasone—NR3C1—hematologic cancer	2.03e-05	0.0232	CrCbGaD
Dexamethasone—Fluorometholone—NR3C1—hematologic cancer	1.98e-05	0.0227	CrCbGaD
Dexamethasone—Fluoxymesterone—ESR1—hematologic cancer	1.93e-05	0.0221	CrCbGaD
Dexamethasone—Methylprednisolone—NR3C1—hematologic cancer	1.92e-05	0.0219	CrCbGaD
Dexamethasone—ABCB1—lymph node—hematologic cancer	1.78e-05	0.00112	CbGeAlD
Dexamethasone—Fluoxymesterone—NR3C1—hematologic cancer	1.7e-05	0.0194	CrCbGaD
Dexamethasone—Triamcinolone—NR3C1—hematologic cancer	1.62e-05	0.0185	CrCbGaD
Dexamethasone—Prednisone—NR3C1—hematologic cancer	1.47e-05	0.0168	CrCbGaD
Dexamethasone—Fluticasone Propionate—NR3C1—hematologic cancer	1.44e-05	0.0165	CrCbGaD
Dexamethasone—Prednisolone—NR3C1—hematologic cancer	1.35e-05	0.0155	CrCbGaD
Dexamethasone—Betamethasone—NR3C1—hematologic cancer	1.32e-05	0.0151	CrCbGaD
Dexamethasone—Hydrocortisone—ABCG2—hematologic cancer	1.2e-05	0.0137	CrCbGaD
Dexamethasone—Fluticasone furoate—ABCB1—hematologic cancer	1.16e-05	0.0133	CrCbGaD
Dexamethasone—Hydrocortisone—NR3C1—hematologic cancer	1.03e-05	0.0118	CrCbGaD
Dexamethasone—Methylprednisolone—ABCB1—hematologic cancer	9.25e-06	0.0106	CrCbGaD
Dexamethasone—Prednisone—ALB—hematologic cancer	7.41e-06	0.00848	CrCbGaD
Dexamethasone—Prednisone—ABCB1—hematologic cancer	7.07e-06	0.00809	CrCbGaD
Dexamethasone—Prednisolone—ABCB1—hematologic cancer	6.52e-06	0.00746	CrCbGaD
Dexamethasone—Betamethasone—ABCB1—hematologic cancer	6.39e-06	0.00731	CrCbGaD
Dexamethasone—Hydrocortisone—ABCB1—hematologic cancer	4.99e-06	0.00571	CrCbGaD
Dexamethasone—Urticaria—Prednisolone—hematologic cancer	3.25e-06	6.04e-05	CcSEcCtD
Dexamethasone—Asthenia—Cisplatin—hematologic cancer	3.25e-06	6.04e-05	CcSEcCtD
Dexamethasone—Fatigue—Triamcinolone—hematologic cancer	3.25e-06	6.03e-05	CcSEcCtD
Dexamethasone—Rash—Vincristine—hematologic cancer	3.23e-06	6e-05	CcSEcCtD
Dexamethasone—Dermatitis—Vincristine—hematologic cancer	3.23e-06	5.99e-05	CcSEcCtD
Dexamethasone—Pain—Triamcinolone—hematologic cancer	3.22e-06	5.98e-05	CcSEcCtD
Dexamethasone—Headache—Vincristine—hematologic cancer	3.21e-06	5.96e-05	CcSEcCtD
Dexamethasone—Loss of consciousness—Prednisone—hematologic cancer	3.21e-06	5.95e-05	CcSEcCtD
Dexamethasone—Hypotension—Betamethasone—hematologic cancer	3.19e-06	5.93e-05	CcSEcCtD
Dexamethasone—Nausea—Carmustine—hematologic cancer	3.19e-06	5.92e-05	CcSEcCtD
Dexamethasone—Angiopathy—Methotrexate—hematologic cancer	3.18e-06	5.9e-05	CcSEcCtD
Dexamethasone—Vomiting—Mitoxantrone—hematologic cancer	3.17e-06	5.89e-05	CcSEcCtD
Dexamethasone—Vomiting—Irinotecan—hematologic cancer	3.17e-06	5.89e-05	CcSEcCtD
Dexamethasone—Nausea—Alitretinoin—hematologic cancer	3.16e-06	5.87e-05	CcSEcCtD
Dexamethasone—Convulsion—Prednisone—hematologic cancer	3.16e-06	5.86e-05	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—hematologic cancer	3.16e-06	5.86e-05	CcSEcCtD
Dexamethasone—Hypertension—Prednisone—hematologic cancer	3.15e-06	5.84e-05	CcSEcCtD
Dexamethasone—Rash—Irinotecan—hematologic cancer	3.15e-06	5.84e-05	CcSEcCtD
Dexamethasone—Rash—Mitoxantrone—hematologic cancer	3.15e-06	5.84e-05	CcSEcCtD
Dexamethasone—Dermatitis—Mitoxantrone—hematologic cancer	3.15e-06	5.84e-05	CcSEcCtD
Dexamethasone—Dermatitis—Irinotecan—hematologic cancer	3.15e-06	5.84e-05	CcSEcCtD
Dexamethasone—Headache—Mitoxantrone—hematologic cancer	3.13e-06	5.81e-05	CcSEcCtD
Dexamethasone—Headache—Irinotecan—hematologic cancer	3.13e-06	5.81e-05	CcSEcCtD
Dexamethasone—Nausea—Ifosfamide—hematologic cancer	3.12e-06	5.8e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.11e-06	5.78e-05	CcSEcCtD
Dexamethasone—Myalgia—Prednisone—hematologic cancer	3.1e-06	5.76e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Triamcinolone—hematologic cancer	3.1e-06	5.76e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Cisplatin—hematologic cancer	3.1e-06	5.76e-05	CcSEcCtD
Dexamethasone—Anxiety—Prednisone—hematologic cancer	3.09e-06	5.74e-05	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—hematologic cancer	3.09e-06	5.74e-05	CcSEcCtD
Dexamethasone—Vomiting—Gemcitabine—hematologic cancer	3.09e-06	5.74e-05	CcSEcCtD
Dexamethasone—Insomnia—Betamethasone—hematologic cancer	3.09e-06	5.74e-05	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—hematologic cancer	3.09e-06	5.73e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Betamethasone—hematologic cancer	3.07e-06	5.7e-05	CcSEcCtD
Dexamethasone—Discomfort—Prednisone—hematologic cancer	3.07e-06	5.69e-05	CcSEcCtD
Dexamethasone—Rash—Gemcitabine—hematologic cancer	3.07e-06	5.69e-05	CcSEcCtD
Dexamethasone—Dermatitis—Gemcitabine—hematologic cancer	3.06e-06	5.69e-05	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—hematologic cancer	3.06e-06	5.68e-05	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—hematologic cancer	3.05e-06	5.66e-05	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—hematologic cancer	3.05e-06	5.66e-05	CcSEcCtD
Dexamethasone—Headache—Gemcitabine—hematologic cancer	3.05e-06	5.65e-05	CcSEcCtD
Dexamethasone—Nausea—Vincristine—hematologic cancer	3.05e-06	5.65e-05	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—hematologic cancer	3.03e-06	5.63e-05	CcSEcCtD
Dexamethasone—Dyspepsia—Betamethasone—hematologic cancer	3.01e-06	5.58e-05	CcSEcCtD
Dexamethasone—Urticaria—Triamcinolone—hematologic cancer	2.99e-06	5.55e-05	CcSEcCtD
Dexamethasone—Asthenia—Etoposide—hematologic cancer	2.98e-06	5.53e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Triamcinolone—hematologic cancer	2.98e-06	5.53e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Prednisone—hematologic cancer	2.98e-06	5.52e-05	CcSEcCtD
Dexamethasone—Oedema—Prednisone—hematologic cancer	2.98e-06	5.52e-05	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—hematologic cancer	2.97e-06	5.52e-05	CcSEcCtD
Dexamethasone—Decreased appetite—Betamethasone—hematologic cancer	2.97e-06	5.51e-05	CcSEcCtD
Dexamethasone—Nausea—Mitoxantrone—hematologic cancer	2.97e-06	5.5e-05	CcSEcCtD
Dexamethasone—Nausea—Irinotecan—hematologic cancer	2.97e-06	5.5e-05	CcSEcCtD
Dexamethasone—Infection—Prednisone—hematologic cancer	2.96e-06	5.49e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.95e-06	5.48e-05	CcSEcCtD
Dexamethasone—Fatigue—Betamethasone—hematologic cancer	2.95e-06	5.47e-05	CcSEcCtD
Dexamethasone—Pruritus—Etoposide—hematologic cancer	2.94e-06	5.45e-05	CcSEcCtD
Dexamethasone—Shock—Prednisone—hematologic cancer	2.93e-06	5.44e-05	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—hematologic cancer	2.93e-06	5.43e-05	CcSEcCtD
Dexamethasone—Pain—Betamethasone—hematologic cancer	2.92e-06	5.42e-05	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—hematologic cancer	2.92e-06	5.42e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Prednisone—hematologic cancer	2.92e-06	5.42e-05	CcSEcCtD
Dexamethasone—Tachycardia—Prednisone—hematologic cancer	2.9e-06	5.39e-05	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—hematologic cancer	2.9e-06	5.37e-05	CcSEcCtD
Dexamethasone—Nausea—Gemcitabine—hematologic cancer	2.89e-06	5.36e-05	CcSEcCtD
Dexamethasone—Vomiting—Cisplatin—hematologic cancer	2.88e-06	5.35e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Prednisone—hematologic cancer	2.88e-06	5.34e-05	CcSEcCtD
Dexamethasone—Rash—Cisplatin—hematologic cancer	2.86e-06	5.3e-05	CcSEcCtD
Dexamethasone—Dermatitis—Cisplatin—hematologic cancer	2.86e-06	5.3e-05	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—hematologic cancer	2.85e-06	5.29e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—hematologic cancer	2.84e-06	5.27e-05	CcSEcCtD
Dexamethasone—Anorexia—Prednisone—hematologic cancer	2.84e-06	5.27e-05	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—hematologic cancer	2.83e-06	5.26e-05	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—hematologic cancer	2.83e-06	5.25e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Betamethasone—hematologic cancer	2.82e-06	5.23e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.79e-06	5.19e-05	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—hematologic cancer	2.75e-06	5.11e-05	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—hematologic cancer	2.75e-06	5.1e-05	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—hematologic cancer	2.75e-06	5.1e-05	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—hematologic cancer	2.74e-06	5.08e-05	CcSEcCtD
Dexamethasone—Urticaria—Betamethasone—hematologic cancer	2.72e-06	5.04e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.71e-06	5.03e-05	CcSEcCtD
Dexamethasone—Dizziness—Prednisolone—hematologic cancer	2.71e-06	5.03e-05	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—hematologic cancer	2.71e-06	5.03e-05	CcSEcCtD
Dexamethasone—Asthenia—Triamcinolone—hematologic cancer	2.7e-06	5.02e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Betamethasone—hematologic cancer	2.7e-06	5.01e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Betamethasone—hematologic cancer	2.7e-06	5.01e-05	CcSEcCtD
Dexamethasone—Nausea—Cisplatin—hematologic cancer	2.69e-06	5e-05	CcSEcCtD
Dexamethasone—Insomnia—Prednisone—hematologic cancer	2.69e-06	5e-05	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—hematologic cancer	2.68e-06	4.97e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Prednisone—hematologic cancer	2.67e-06	4.96e-05	CcSEcCtD
Dexamethasone—Pruritus—Triamcinolone—hematologic cancer	2.66e-06	4.95e-05	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—hematologic cancer	2.65e-06	4.91e-05	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—hematologic cancer	2.64e-06	4.9e-05	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—hematologic cancer	2.64e-06	4.9e-05	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—hematologic cancer	2.64e-06	4.9e-05	CcSEcCtD
Dexamethasone—Dyspepsia—Prednisone—hematologic cancer	2.62e-06	4.86e-05	CcSEcCtD
Dexamethasone—Rash—Etoposide—hematologic cancer	2.62e-06	4.86e-05	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—hematologic cancer	2.62e-06	4.86e-05	CcSEcCtD
Dexamethasone—Headache—Etoposide—hematologic cancer	2.6e-06	4.83e-05	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—hematologic cancer	2.59e-06	4.82e-05	CcSEcCtD
Dexamethasone—Decreased appetite—Prednisone—hematologic cancer	2.59e-06	4.8e-05	CcSEcCtD
Dexamethasone—Rash—Prednisolone—hematologic cancer	2.58e-06	4.79e-05	CcSEcCtD
Dexamethasone—Dermatitis—Prednisolone—hematologic cancer	2.58e-06	4.79e-05	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—hematologic cancer	2.57e-06	4.77e-05	CcSEcCtD
Dexamethasone—Fatigue—Prednisone—hematologic cancer	2.57e-06	4.76e-05	CcSEcCtD
Dexamethasone—Headache—Prednisolone—hematologic cancer	2.57e-06	4.76e-05	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—hematologic cancer	2.56e-06	4.76e-05	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—hematologic cancer	2.56e-06	4.76e-05	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—hematologic cancer	2.56e-06	4.75e-05	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—hematologic cancer	2.51e-06	4.65e-05	CcSEcCtD
Dexamethasone—Dizziness—Triamcinolone—hematologic cancer	2.49e-06	4.62e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—hematologic cancer	2.49e-06	4.62e-05	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—hematologic cancer	2.47e-06	4.59e-05	CcSEcCtD
Dexamethasone—Infection—Methotrexate—hematologic cancer	2.47e-06	4.59e-05	CcSEcCtD
Dexamethasone—Nausea—Etoposide—hematologic cancer	2.47e-06	4.58e-05	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—hematologic cancer	2.46e-06	4.57e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Prednisone—hematologic cancer	2.45e-06	4.55e-05	CcSEcCtD
Dexamethasone—Asthenia—Betamethasone—hematologic cancer	2.45e-06	4.55e-05	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.45e-06	4.54e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—hematologic cancer	2.44e-06	4.53e-05	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—hematologic cancer	2.44e-06	4.52e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Prednisone—hematologic cancer	2.43e-06	4.52e-05	CcSEcCtD
Dexamethasone—Nausea—Prednisolone—hematologic cancer	2.43e-06	4.52e-05	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—hematologic cancer	2.43e-06	4.51e-05	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—hematologic cancer	2.42e-06	4.49e-05	CcSEcCtD
Dexamethasone—Pruritus—Betamethasone—hematologic cancer	2.42e-06	4.49e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—hematologic cancer	2.4e-06	4.46e-05	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—hematologic cancer	2.4e-06	4.45e-05	CcSEcCtD
Dexamethasone—Vomiting—Triamcinolone—hematologic cancer	2.39e-06	4.45e-05	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—hematologic cancer	2.38e-06	4.42e-05	CcSEcCtD
Dexamethasone—Rash—Triamcinolone—hematologic cancer	2.38e-06	4.41e-05	CcSEcCtD
Dexamethasone—Dermatitis—Triamcinolone—hematologic cancer	2.37e-06	4.4e-05	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—hematologic cancer	2.37e-06	4.4e-05	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—hematologic cancer	2.37e-06	4.4e-05	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—hematologic cancer	2.37e-06	4.39e-05	CcSEcCtD
Dexamethasone—Urticaria—Prednisone—hematologic cancer	2.36e-06	4.39e-05	CcSEcCtD
Dexamethasone—Headache—Triamcinolone—hematologic cancer	2.36e-06	4.38e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Prednisone—hematologic cancer	2.35e-06	4.37e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Prednisone—hematologic cancer	2.35e-06	4.37e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Betamethasone—hematologic cancer	2.34e-06	4.34e-05	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—hematologic cancer	2.33e-06	4.32e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—hematologic cancer	2.33e-06	4.32e-05	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—hematologic cancer	2.32e-06	4.31e-05	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—hematologic cancer	2.32e-06	4.31e-05	CcSEcCtD
Dexamethasone—Infection—Epirubicin—hematologic cancer	2.31e-06	4.29e-05	CcSEcCtD
Dexamethasone—Shock—Epirubicin—hematologic cancer	2.29e-06	4.25e-05	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—hematologic cancer	2.29e-06	4.24e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—hematologic cancer	2.28e-06	4.24e-05	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—hematologic cancer	2.28e-06	4.23e-05	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—hematologic cancer	2.28e-06	4.23e-05	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—hematologic cancer	2.27e-06	4.22e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.27e-06	4.21e-05	CcSEcCtD
Dexamethasone—Dizziness—Betamethasone—hematologic cancer	2.26e-06	4.19e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—hematologic cancer	2.25e-06	4.18e-05	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—hematologic cancer	2.25e-06	4.18e-05	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—hematologic cancer	2.25e-06	4.17e-05	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—hematologic cancer	2.24e-06	4.16e-05	CcSEcCtD
Dexamethasone—Nausea—Triamcinolone—hematologic cancer	2.24e-06	4.15e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—hematologic cancer	2.23e-06	4.15e-05	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—hematologic cancer	2.22e-06	4.12e-05	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—hematologic cancer	2.22e-06	4.12e-05	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—hematologic cancer	2.19e-06	4.06e-05	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—hematologic cancer	2.18e-06	4.04e-05	CcSEcCtD
Dexamethasone—Vomiting—Betamethasone—hematologic cancer	2.17e-06	4.03e-05	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—hematologic cancer	2.16e-06	4.01e-05	CcSEcCtD
Dexamethasone—Rash—Betamethasone—hematologic cancer	2.15e-06	4e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.15e-06	4e-05	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—hematologic cancer	2.15e-06	4e-05	CcSEcCtD
Dexamethasone—Dermatitis—Betamethasone—hematologic cancer	2.15e-06	4e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.15e-06	3.99e-05	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—hematologic cancer	2.14e-06	3.98e-05	CcSEcCtD
Dexamethasone—Headache—Betamethasone—hematologic cancer	2.14e-06	3.97e-05	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—hematologic cancer	2.14e-06	3.97e-05	CcSEcCtD
Dexamethasone—Asthenia—Prednisone—hematologic cancer	2.14e-06	3.96e-05	CcSEcCtD
Dexamethasone—Pain—Methotrexate—hematologic cancer	2.13e-06	3.95e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.12e-06	3.94e-05	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—hematologic cancer	2.12e-06	3.93e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—hematologic cancer	2.11e-06	3.92e-05	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—hematologic cancer	2.11e-06	3.91e-05	CcSEcCtD
Dexamethasone—Pruritus—Prednisone—hematologic cancer	2.11e-06	3.91e-05	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—hematologic cancer	2.11e-06	3.91e-05	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—hematologic cancer	2.1e-06	3.9e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—hematologic cancer	2.09e-06	3.88e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.08e-06	3.86e-05	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—hematologic cancer	2.05e-06	3.81e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—hematologic cancer	2.05e-06	3.8e-05	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—hematologic cancer	2.05e-06	3.8e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Prednisone—hematologic cancer	2.04e-06	3.78e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.03e-06	3.78e-05	CcSEcCtD
Dexamethasone—Nausea—Betamethasone—hematologic cancer	2.03e-06	3.77e-05	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—hematologic cancer	2.02e-06	3.76e-05	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—hematologic cancer	2.01e-06	3.74e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.01e-06	3.73e-05	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—hematologic cancer	2.01e-06	3.73e-05	CcSEcCtD
Dexamethasone—Pain—Epirubicin—hematologic cancer	1.99e-06	3.69e-05	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—hematologic cancer	1.98e-06	3.67e-05	CcSEcCtD
Dexamethasone—Dizziness—Prednisone—hematologic cancer	1.97e-06	3.65e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—hematologic cancer	1.97e-06	3.65e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—hematologic cancer	1.97e-06	3.65e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.96e-06	3.64e-05	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—hematologic cancer	1.95e-06	3.62e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—hematologic cancer	1.93e-06	3.59e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—hematologic cancer	1.92e-06	3.56e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.9e-06	3.53e-05	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—hematologic cancer	1.9e-06	3.52e-05	CcSEcCtD
Dexamethasone—Vomiting—Prednisone—hematologic cancer	1.89e-06	3.51e-05	CcSEcCtD
Dexamethasone—Rash—Prednisone—hematologic cancer	1.88e-06	3.48e-05	CcSEcCtD
Dexamethasone—Dermatitis—Prednisone—hematologic cancer	1.87e-06	3.48e-05	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—hematologic cancer	1.87e-06	3.48e-05	CcSEcCtD
Dexamethasone—Headache—Prednisone—hematologic cancer	1.86e-06	3.46e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.86e-06	3.45e-05	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—hematologic cancer	1.86e-06	3.45e-05	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—hematologic cancer	1.85e-06	3.43e-05	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—hematologic cancer	1.84e-06	3.42e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—hematologic cancer	1.84e-06	3.42e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—hematologic cancer	1.84e-06	3.42e-05	CcSEcCtD
Dexamethasone—Asthenia—Methotrexate—hematologic cancer	1.78e-06	3.31e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—hematologic cancer	1.77e-06	3.29e-05	CcSEcCtD
Dexamethasone—Nausea—Prednisone—hematologic cancer	1.77e-06	3.28e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.76e-06	3.27e-05	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—hematologic cancer	1.76e-06	3.27e-05	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—hematologic cancer	1.71e-06	3.18e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—hematologic cancer	1.7e-06	3.16e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—hematologic cancer	1.7e-06	3.16e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—hematologic cancer	1.7e-06	3.16e-05	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—hematologic cancer	1.67e-06	3.1e-05	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—hematologic cancer	1.65e-06	3.06e-05	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—hematologic cancer	1.64e-06	3.05e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—hematologic cancer	1.59e-06	2.96e-05	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—hematologic cancer	1.58e-06	2.94e-05	CcSEcCtD
Dexamethasone—Rash—Methotrexate—hematologic cancer	1.57e-06	2.91e-05	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—hematologic cancer	1.57e-06	2.91e-05	CcSEcCtD
Dexamethasone—Headache—Methotrexate—hematologic cancer	1.56e-06	2.89e-05	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—hematologic cancer	1.55e-06	2.87e-05	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—hematologic cancer	1.54e-06	2.86e-05	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—hematologic cancer	1.52e-06	2.83e-05	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—hematologic cancer	1.48e-06	2.75e-05	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—hematologic cancer	1.48e-06	2.74e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—hematologic cancer	1.47e-06	2.74e-05	CcSEcCtD
Dexamethasone—Rash—Epirubicin—hematologic cancer	1.47e-06	2.72e-05	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—hematologic cancer	1.47e-06	2.72e-05	CcSEcCtD
Dexamethasone—Headache—Epirubicin—hematologic cancer	1.46e-06	2.71e-05	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—hematologic cancer	1.42e-06	2.64e-05	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—hematologic cancer	1.38e-06	2.57e-05	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—hematologic cancer	1.37e-06	2.54e-05	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—hematologic cancer	1.36e-06	2.52e-05	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—hematologic cancer	1.36e-06	2.52e-05	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—hematologic cancer	1.35e-06	2.5e-05	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—hematologic cancer	1.28e-06	2.37e-05	CcSEcCtD
Dexamethasone—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.44e-07	1.26e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—hematologic cancer	3.44e-07	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.44e-07	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.43e-07	1.26e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYCS—hematologic cancer	3.41e-07	1.25e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6R—hematologic cancer	3.4e-07	1.25e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CREBBP—hematologic cancer	3.4e-07	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.39e-07	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CB—hematologic cancer	3.39e-07	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.39e-07	1.24e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYCS—hematologic cancer	3.38e-07	1.24e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTEN—hematologic cancer	3.36e-07	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.36e-07	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.36e-07	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.36e-07	1.23e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.34e-07	1.22e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.34e-07	1.22e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3R1—hematologic cancer	3.34e-07	1.22e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MAPK3—hematologic cancer	3.31e-07	1.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.31e-07	1.21e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.31e-07	1.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.27e-07	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.26e-07	1.19e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAP2K1—hematologic cancer	3.24e-07	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MTHFR—hematologic cancer	3.24e-07	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—hematologic cancer	3.24e-07	1.19e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—hematologic cancer	3.22e-07	1.18e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CD—hematologic cancer	3.22e-07	1.18e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.22e-07	1.18e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFB1—hematologic cancer	3.22e-07	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.21e-07	1.18e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—EP300—hematologic cancer	3.21e-07	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—hematologic cancer	3.21e-07	1.17e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTP1—hematologic cancer	3.19e-07	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ALB—hematologic cancer	3.17e-07	1.16e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.16e-07	1.16e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NUP98—hematologic cancer	3.15e-07	1.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.09e-07	1.13e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGF2—hematologic cancer	3.08e-07	1.13e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CB—hematologic cancer	3.08e-07	1.13e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—hematologic cancer	3.07e-07	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.06e-07	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.06e-07	1.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.06e-07	1.12e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3R1—hematologic cancer	3.04e-07	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NUP214—hematologic cancer	3.04e-07	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—hematologic cancer	3.04e-07	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.03e-07	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.02e-07	1.11e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—hematologic cancer	3e-07	1.1e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NCOR1—hematologic cancer	3e-07	1.1e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTM1—hematologic cancer	3e-07	1.1e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.98e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTR—hematologic cancer	2.98e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—hematologic cancer	2.98e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.98e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.97e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—JAK2—hematologic cancer	2.96e-07	1.08e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.95e-07	1.08e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.95e-07	1.08e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTM1—hematologic cancer	2.93e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NCOR1—hematologic cancer	2.93e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—hematologic cancer	2.93e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO2—hematologic cancer	2.92e-07	1.07e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—EP300—hematologic cancer	2.9e-07	1.06e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—hematologic cancer	2.89e-07	1.06e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.89e-07	1.06e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—hematologic cancer	2.89e-07	1.06e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.88e-07	1.06e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.88e-07	1.05e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—hematologic cancer	2.87e-07	1.05e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.86e-07	1.05e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CREBBP—hematologic cancer	2.84e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.84e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—hematologic cancer	2.84e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.83e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.82e-07	1.03e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTOR—hematologic cancer	2.81e-07	1.03e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CB—hematologic cancer	2.81e-07	1.03e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—hematologic cancer	2.8e-07	1.03e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.8e-07	1.03e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—EP300—hematologic cancer	2.79e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SDC1—hematologic cancer	2.77e-07	1.01e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.76e-07	1.01e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.76e-07	1.01e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.74e-07	1e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.74e-07	1e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—hematologic cancer	2.74e-07	1e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.73e-07	1e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.72e-07	9.97e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CD—hematologic cancer	2.7e-07	9.87e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.68e-07	9.8e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.67e-07	9.78e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—hematologic cancer	2.66e-07	9.75e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—hematologic cancer	2.66e-07	9.75e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.65e-07	9.71e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—hematologic cancer	2.65e-07	9.69e-06	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—hematologic cancer	2.65e-07	9.68e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—hematologic cancer	2.64e-07	9.67e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1B—hematologic cancer	2.63e-07	9.65e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.62e-07	9.59e-06	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—hematologic cancer	2.62e-07	9.59e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.59e-07	9.49e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—hematologic cancer	2.59e-07	9.48e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—hematologic cancer	2.56e-07	9.37e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.55e-07	9.32e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—EP300—hematologic cancer	2.54e-07	9.3e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.54e-07	9.3e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.53e-07	9.28e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—hematologic cancer	2.53e-07	9.27e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CREBBP—hematologic cancer	2.52e-07	9.24e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—EP300—hematologic cancer	2.52e-07	9.22e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—hematologic cancer	2.51e-07	9.18e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—hematologic cancer	2.5e-07	9.16e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.5e-07	9.14e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.45e-07	8.96e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.44e-07	8.93e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1A—hematologic cancer	2.43e-07	8.9e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—hematologic cancer	2.43e-07	8.88e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—hematologic cancer	2.42e-07	8.87e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—hematologic cancer	2.42e-07	8.86e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.42e-07	8.85e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.4e-07	8.78e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.39e-07	8.76e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.39e-07	8.76e-06	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	2.37e-07	8.69e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—hematologic cancer	2.36e-07	8.65e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CD44—hematologic cancer	2.35e-07	8.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.35e-07	8.62e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.35e-07	8.61e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.34e-07	8.56e-06	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—hematologic cancer	2.32e-07	8.5e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.31e-07	8.47e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EP300—hematologic cancer	2.31e-07	8.47e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—EP300—hematologic cancer	2.31e-07	8.45e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.26e-07	8.28e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.26e-07	8.27e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SRC—hematologic cancer	2.25e-07	8.24e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—hematologic cancer	2.23e-07	8.18e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.23e-07	8.16e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.23e-07	8.16e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.21e-07	8.1e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.21e-07	8.1e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.21e-07	8.09e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.19e-07	8.04e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.18e-07	7.96e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—hematologic cancer	2.17e-07	7.94e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—hematologic cancer	2.17e-07	7.93e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—hematologic cancer	2.16e-07	7.92e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—hematologic cancer	2.15e-07	7.85e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.13e-07	7.8e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.09e-07	7.64e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK3—hematologic cancer	2.07e-07	7.59e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.07e-07	7.59e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.07e-07	7.56e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—hematologic cancer	2.07e-07	7.56e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.05e-07	7.5e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.03e-07	7.44e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—hematologic cancer	2.03e-07	7.44e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CREBBP—hematologic cancer	2.02e-07	7.38e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—hematologic cancer	2.02e-07	7.38e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—hematologic cancer	2.01e-07	7.36e-06	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—hematologic cancer	1.99e-07	7.27e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.96e-07	7.19e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.96e-07	7.17e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—hematologic cancer	1.95e-07	7.15e-06	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.94e-07	7.1e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—EP300—hematologic cancer	1.94e-07	7.09e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—hematologic cancer	1.93e-07	7.08e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.91e-07	7e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—hematologic cancer	1.91e-07	7e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.91e-07	7e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—hematologic cancer	1.91e-07	6.99e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.9e-07	6.96e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—hematologic cancer	1.89e-07	6.91e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.88e-07	6.9e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.88e-07	6.88e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—hematologic cancer	1.86e-07	6.82e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.86e-07	6.82e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—EP300—hematologic cancer	1.86e-07	6.82e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.86e-07	6.81e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.85e-07	6.77e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—EP300—hematologic cancer	1.82e-07	6.68e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—EP300—hematologic cancer	1.82e-07	6.66e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.81e-07	6.61e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.8e-07	6.61e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.8e-07	6.61e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—hematologic cancer	1.8e-07	6.6e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.8e-07	6.6e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.79e-07	6.54e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—hematologic cancer	1.78e-07	6.51e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—hematologic cancer	1.76e-07	6.46e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—hematologic cancer	1.75e-07	6.41e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—EP300—hematologic cancer	1.72e-07	6.3e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—hematologic cancer	1.71e-07	6.27e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.71e-07	6.25e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.71e-07	6.25e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.7e-07	6.23e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—hematologic cancer	1.69e-07	6.18e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.69e-07	6.18e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.67e-07	6.1e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.65e-07	6.05e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.6e-07	5.84e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—hematologic cancer	1.58e-07	5.8e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—EP300—hematologic cancer	1.58e-07	5.77e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.57e-07	5.75e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.56e-07	5.7e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—hematologic cancer	1.54e-07	5.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.52e-07	5.57e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—hematologic cancer	1.52e-07	5.55e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—hematologic cancer	1.48e-07	5.4e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—hematologic cancer	1.44e-07	5.27e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.43e-07	5.25e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—EP300—hematologic cancer	1.41e-07	5.15e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—hematologic cancer	1.4e-07	5.12e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—hematologic cancer	1.39e-07	5.11e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.38e-07	5.04e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—EP300—hematologic cancer	1.37e-07	5.03e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.36e-07	4.97e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.35e-07	4.94e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.35e-07	4.93e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.35e-07	4.93e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.34e-07	4.91e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—EP300—hematologic cancer	1.29e-07	4.74e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—EP300—hematologic cancer	1.28e-07	4.7e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.27e-07	4.66e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.24e-07	4.55e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.18e-07	4.31e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—hematologic cancer	1.17e-07	4.29e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.17e-07	4.27e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—hematologic cancer	1.16e-07	4.26e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—hematologic cancer	1.13e-07	4.12e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.11e-07	4.07e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—hematologic cancer	1.1e-07	4.04e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—hematologic cancer	1.1e-07	4.03e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.04e-07	3.81e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—hematologic cancer	1.04e-07	3.8e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.03e-07	3.76e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.02e-07	3.72e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.57e-08	3.51e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—hematologic cancer	9.53e-08	3.49e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.49e-08	3.47e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—hematologic cancer	8.87e-08	3.25e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—hematologic cancer	8.5e-08	3.11e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—EP300—hematologic cancer	8.46e-08	3.1e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—hematologic cancer	8.3e-08	3.04e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—hematologic cancer	7.82e-08	2.86e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—hematologic cancer	7.75e-08	2.84e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.26e-08	2.29e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—hematologic cancer	5.11e-08	1.87e-06	CbGpPWpGaD
